PAUL L BERNS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PAUL L BERNS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL L BERNS. PAUL L BERNS is President/CEO in BONE CARE INTERNATIONAL INC ($BCII) and Director in XENOPORT INC ($XNPT) and Director in Jazz Pharmaceuticals plc ($JAZZ) and Director in Cellectar Biosciences, Inc. ($CLRB) and President and CEO in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in Unity Biotechnology, Inc. ($UBX) and Director in Menlo Therapeutics Inc. ($MNLO).
Latest Insider Trading Transactions of PAUL L BERNS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, BCII, CLRB, JAZZ, UBX, MNLO, XNPT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28 2021 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 4.18 | 25,000 | 104,500 | 25,000 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 125.87 | 931 | 117,185 | 9,740 | 10.7 K to 9.7 K (-8.72 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 2,705 | 0 | 10,671 | 8 K to 10.7 K (+33.96 %) |
| Jun 22 2020 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 9.14 | 25,000 | 228,500 | 25,000 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 135.65 | 726 | 98,481 | 7,966 | 8.7 K to 8 K (-8.35 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,920 | 0 | 8,692 | 6.8 K to 8.7 K (+28.35 %) |
| Jun 27 2019 | MNLO | Menlo Therapeutics ... | BERNS PAUL L | Director | Option Exercise | A | 6.02 | 22,500 | 135,450 | 65,780 | |
| Jun 24 2019 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | A | 9.00 | 25,000 | 225,000 | 25,000 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 176.61 | 660 | 116,563 | 6,772 | 7.4 K to 6.8 K (-8.88 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,495 | 0 | 7,432 | 5.9 K to 7.4 K (+25.18 %) |
| May 07 2018 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Option Exercise | C | 0.00 | 3,261 | 0 | 0 | |
| May 07 2018 | UBX | Unity Biotechnolog ... | BERNS PAUL L | Director | Buy | C | 0.00 | 3,261 | 0 | 3,261 | 0 to 3.3 K |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 144.13 | 3 | 432 | 5,937 | 5.9 K to 5.9 K (-0.05 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 142.36 | 659 | 93,815 | 5,940 | 6.6 K to 5.9 K (-9.99 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,365 | 0 | 6,599 | 5.2 K to 6.6 K (+26.08 %) |
| Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 136.45 | 633 | 86,373 | 5,234 | 5.9 K to 5.2 K (-10.79 %) |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,365 | 0 | 5,867 | 4.5 K to 5.9 K (+30.32 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 78.91 | 73,788 | 5,822,611 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 78.91 | 73,788 | 5,822,611 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 37.81 | 84,100 | 3,179,821 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 37.81 | 84,100 | 3,179,821 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 21.21 | 394,000 | 8,356,740 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 21.21 | 394,000 | 8,356,740 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 14,584 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 14,584 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 12,890 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | D | 0.00 | 12,890 | 0 | 0 | |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | D | 99.25 | 231,311 | 22,957,617 | 0 | 231.3 K to 0 (-100.00 %) |
| Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | D | 99.25 | 231,311 | 22,957,617 | 0 | 231.3 K to 0 (-100.00 %) |
| May 19 2016 | XNPT | XENOPORT INC | BERNS PAUL L | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 19 2016 | XNPT | XENOPORT INC | BERNS PAUL L | Director | Buy | M | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) |
| Mar 22 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 60.46 | 27,800 | 1,680,680 | 230,311 | 258.1 K to 230.3 K (-10.77 %) |
| Mar 22 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 59.89 | 9,700 | 580,936 | 258,111 | 267.8 K to 258.1 K (-3.62 %) |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | A | 0.00 | 14,584 | 0 | 14,584 | |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | A | 78.91 | 73,788 | 5,822,611 | 73,788 | |
| Feb 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Grant | A | 0.00 | 14,584 | 0 | 267,811 | 253.2 K to 267.8 K (+5.76 %) |
| Apr 21 2016 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Option Exercise | P | 3.04 | 117,371 | 356,808 | 117,371 | |
| Apr 21 2016 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Buy | P | 2.12 | 117,371 | 248,827 | 117,371 | 0 to 117.4 K |
| Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 112.98 | 233 | 26,325 | 252,227 | 252.5 K to 252.2 K (-0.09 %) |
| Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 112.33 | 2,220 | 249,380 | 252,460 | 254.7 K to 252.5 K (-0.87 %) |
| Jan 05 2016 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 110.97 | 80 | 8,878 | 254,680 | 254.8 K to 254.7 K (-0.03 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 21.21 | 6,000 | 127,260 | 294,000 | |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.20 | 14,000 | 72,800 | 0 | |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 118.59 | 500 | 59,294 | 254,760 | 255.3 K to 254.8 K (-0.20 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 117.60 | 8,178 | 961,744 | 255,260 | 263.4 K to 255.3 K (-3.10 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 117.04 | 10,732 | 1,256,050 | 263,438 | 274.2 K to 263.4 K (-3.91 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 115.52 | 590 | 68,159 | 274,170 | 274.8 K to 274.2 K (-0.21 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 21.21 | 6,000 | 127,260 | 274,760 | 268.8 K to 274.8 K (+2.23 %) |
| Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.20 | 14,000 | 72,800 | 268,760 | 254.8 K to 268.8 K (+5.50 %) |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.20 | 16,000 | 83,200 | 14,000 | |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.11 | 4,000 | 20,440 | 0 | |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 140.64 | 1,799 | 253,006 | 254,760 | 256.6 K to 254.8 K (-0.70 %) |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 139.83 | 16,209 | 2,266,573 | 256,559 | 272.8 K to 256.6 K (-5.94 %) |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 139.03 | 1,992 | 276,950 | 272,768 | 274.8 K to 272.8 K (-0.72 %) |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.20 | 16,000 | 83,200 | 274,760 | 258.8 K to 274.8 K (+6.18 %) |
| Sep 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.11 | 4,000 | 20,440 | 258,760 | 254.8 K to 258.8 K (+1.57 %) |
| Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Option Exercise | M | 5.11 | 20,000 | 102,200 | 4,000 | |
| Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 139.45 | 11,575 | 1,614,076 | 254,760 | 266.3 K to 254.8 K (-4.35 %) |
| Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 138.40 | 3,281 | 454,081 | 266,335 | 269.6 K to 266.3 K (-1.22 %) |
| Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 137.53 | 3,489 | 479,824 | 269,616 | 273.1 K to 269.6 K (-1.28 %) |
| Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 136.49 | 1,655 | 225,897 | 273,105 | 274.8 K to 273.1 K (-0.60 %) |
| Aug 17 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Buy | M | 5.11 | 20,000 | 102,200 | 274,760 | 254.8 K to 274.8 K (+7.85 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 183.36 | 4 | 733 | 5,589 | 5.6 K to 5.6 K (-0.07 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 179.98 | 797 | 143,444 | 5,593 | 6.4 K to 5.6 K (-12.47 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 1,310 | 0 | 6,390 | 5.1 K to 6.4 K (+25.79 %) |
| Jun 10 2015 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Option Exercise | A | 2.64 | 5,000 | 13,200 | 5,000 | |
| May 21 2015 | XNPT | XENOPORT INC | BERNS PAUL L | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
| May 21 2015 | XNPT | XENOPORT INC | BERNS PAUL L | Director | Option Exercise | A | 6.04 | 15,000 | 90,600 | 15,000 | |
| May 21 2015 | XNPT | XENOPORT INC | BERNS PAUL L | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | |
| May 21 2015 | XNPT | XENOPORT INC | BERNS PAUL L | Director | Buy | M | 0.00 | 5,000 | 0 | 10,000 | 5 K to 10 K (+100.00 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 63.85 | 9,750 | 622,582 | 253,760 | 263.5 K to 253.8 K (-3.70 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 62.68 | 3,448 | 216,137 | 263,510 | 267 K to 263.5 K (-1.29 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 61.74 | 2,100 | 129,658 | 266,958 | 269.1 K to 267 K (-0.78 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 60.46 | 2,078 | 125,632 | 269,058 | 271.1 K to 269.1 K (-0.77 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 59.79 | 7,624 | 455,835 | 271,136 | 278.8 K to 271.1 K (-2.73 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 66.31 | 900 | 59,683 | 278,760 | 279.7 K to 278.8 K (-0.32 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 65.51 | 16,267 | 1,065,597 | 279,660 | 295.9 K to 279.7 K (-5.50 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 64.69 | 7,833 | 506,696 | 295,927 | 303.8 K to 295.9 K (-2.58 %) |
| Apr 28 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Gift | G | 0.00 | 5,000 | 0 | 303,760 | 308.8 K to 303.8 K (-1.62 %) |
| Mar 23 2015 | ANAC | Anacor Pharmaceuti ... | BERNS PAUL L | President and CEO | Sell | S | 56.07 | 37,500 | 2,102,644 | 308,760 | 346.3 K to 308.8 K (-10.83 %) |
| Mar 04 2015 | CLRB | Cellectar Bioscien ... | BERNS PAUL L | Director | Option Exercise | A | 2.69 | 5,000 | 13,450 | 5,000 | |
| Jul 01 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | D | 21.12 | 30,000 | 633,600 | 0 | |
| Jul 01 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | D | 12.25 | 50,000 | 612,500 | 0 | |
| Jul 01 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | D | 3.40 | 162,500 | 552,500 | 0 | |
| Jul 01 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Sell | D | 33.00 | 23,334 | 770,022 | 0 | 23.3 K to 0 (-100.00 %) |
| Jul 01 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Sell | D | 33.00 | 242,500 | 8,002,500 | 0 | 242.5 K to 0 (-100.00 %) |
| Jun 23 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Sell | D | 32.90 | 11,667 | 383,844 | 256,111 | 267.8 K to 256.1 K (-4.36 %) |
| Apr 06 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 12,500 | 42,500 | 156,945 | |
| Feb 03 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 4,444 | 15,110 | 150,000 | |
| Feb 03 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 10,000 | 34,000 | 154,444 | |
| Feb 03 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 1,000 | 3,400 | 164,444 | |
| Feb 02 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 9,556 | 32,490 | 165,444 | |
| Jan 05 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 10,000 | 34,000 | 200,000 | |
| Jan 05 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 15,000 | 51,000 | 210,000 | |
| Jan 05 2005 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 25,000 | 85,000 | 225,000 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 45,000 | 153,000 | 205,555 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 5,000 | 17,000 | 250,555 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 12,500 | 42,500 | 255,555 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 10,000 | 34,000 | 268,055 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 25,000 | 85,000 | 278,055 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 2,500 | 8,500 | 303,055 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 7,500 | 25,500 | 305,555 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 2,500 | 8,500 | 313,055 | |
| Dec 29 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Sell | S | 26.01 | 5,000 | 130,060 | 315,555 | 320.6 K to 315.6 K (-1.56 %) |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 12,500 | 42,500 | 255,555 | |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 10,000 | 34,000 | 268,055 | |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 25,000 | 85,000 | 278,055 | |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 2,500 | 8,500 | 303,055 | |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 7,500 | 25,500 | 305,555 | |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | M | 3.40 | 2,500 | 8,500 | 313,055 | |
| Dec 22 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Sell | S | 26.01 | 5,000 | 130,060 | 315,555 | 320.6 K to 315.6 K (-1.56 %) |
| Jun 24 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Option Exercise | A | 21.12 | 30,000 | 633,600 | 0 | |
| Jun 24 2004 | BCII | BONE CARE INTERNAT ... | BERNS PAUL L | President/CEO | Grant | A | 0.00 | 35,000 | 0 | 248,333 | 213.3 K to 248.3 K (+16.41 %) |
Page: 1